48-HOUR REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

<img src="https://api.newsfilecorp.com/newsinfo/313023/208" id="208" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;">San Diego, California--(Newsfile Corp. - September 12, 2026) - <a href="https://api.newsfilecorp.com/redirect/N3Ww2IKqJ4" rel="noopener nofollow" target="_blank"><b>Robbins Geller Rudman Dowd LLP</b></a>...